MARK2 - EP300

SDL interaction

Gene Name	Gene ID	Diseases	Drugs	GO terms	Orthologs
MARK2	ENSG00000072518	No diseases in record	No drugs in record	magnesium ion binding protein serine/threonine kinase activity protein binding ATP binding lipid binding protein kinase activator activity tau-protein kinase activity cadherin binding involved in cell-cell adhesion	par-1 (C. elegans) par-1 (D. melanogaster)
EP300	ENSG00000100393	colorectal breast pancreatic AML ALL DLBCL	No drugs in record	RNA polymerase II core promoter sequence-specific DNA binding core promoter binding RNA polymerase II activating transcription factor binding transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding p53 binding DNA binding chromatin binding damaged DNA binding transcription coactivator activity histone acetyltransferase activity lysine N-acetyltransferase activity, acting on acetyl phosphate as donor protein binding beta-catenin binding protein C-terminus binding transcription factor binding zinc ion binding acetyltransferase activity transferase activity, transferring acyl groups chromatin DNA binding activating transcription factor binding peptide N-acetyltransferase activity nuclear hormone receptor binding androgen receptor binding pre-mRNA intronic binding	BDF1 (S. cerevisiae) BDF2 (S. cerevisiae) nej (D. melanogaster)